Concord Biotech

Price Chart

• Concord Biotech (or, "The Company") is an India-based biopharma company. It is one of the global developers and manufacturers of select fermentation-based APIs across immunosuppressants, anti-infectives, and oncology therapies.
• The company is a vertically integrated, R&D-driven bio-pharma company, that specializes in manufacturing Active Pharmaceutical Ingredients using fermentation & semi-synthetic processes, as well as finished formulations.
  
• The company has a portfolio of 22 fermentation-based APIs and 65 approved products for formulations.
• The company also offers Contract Research and Manufacturing Services (CRAMS), whereby it collaborates with third-party pharmaceutical companies to develop APIs and formulations.
  
• Established in 2000, the Company has evolved from a single-product entity to a versatile solution provider, catering to various therapeutic segments.
• The company's current business model comprises an integrated platform that involves conducting R&D activities, patent filing, manufacturing Key Starting Materials (KSMs) and APIs, producing formulations, and handling the marketing and distribution of these products.
  
• During FY22, the company commissioned its new fermentation-based API facility at Limbasi, which is one of the largest fermentation facilities in the world.
• The Company's API manufacturing facilities are situated in Dholka and Limbasi, while its formulations facility is located in Valthera, Gujarat, India.
  
• The company's journey began as 'Servomed Pharmaceuticals Private Limited' in Ahmedabad, Gujarat on November 23, 1984. Subsequently, it was renamed to 'Concord Pharmaceuticals Private Limited.' The registered office is located in Dholka, Ahmedabad (Gujarat).